Skip to content

Improvement of the severity of peripheral facial nerve palsy by surface electrical stimulation quantified with established and euclidean ratings

Improvement of the severity of peripheral facial nerve palsy by surface electrical stimulation quantified with established and euclidean ratings

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00026940
Enrollment
11
Registered
2021-10-28
Start date
2022-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G51.0

Interventions

Group 1: Patients with peripheral facial paralysis with electrical stimulation Group 2: Patients with peripheral facial paralysis without electrical stimulation (historical)

Sponsors

MED-EL Elektromedizinische Geräte GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age = 18 years - Diagnosed denervation of the zygomaticus on one side - Anatomically and physiologically compatible with the criteria for participation in the clinical trial - Mentally and physically able to use the external stimulator independently at home apply - High motivation combined with realistic expectations regarding the Participation in the clinical trial. - Signed and dated patient information and declaration of consent before carrying out any procedures relevant to the examination.

Exclusion criteria

Exclusion criteria: Lack of compliance with any inclusion criteria - Pregnant or breastfeeding women - Partial reinnervation of the zygomaticus muscle - Any conservative treatment method (e.g. injections with botulinum toxin and / or wrinkle injection) in the face and head area or physical therapy measures to treat denervation of the zygomaticus muscle in the last 3 months prior to inclusion in this clinical trial - Any prior surgical treatment for symptoms of denervation of the zygomaticus muscle - Other clinical conditions affecting the results of this clinical trial could influence (general muscle diseases; epilepsy; skin diseases) - Carrier of an active medical implant - Known allergies or intolerances to materials used in used in clinical trials. - Simultaneous participation in other drug or medical device studies, that could affect the results of this clinical trial - Anything in the opinion of the investigator puts the patient at increased risk could expose, or compromise patient compliance could or what a successful completion of the clinical trial

Design outcomes

Primary

MeasureTime frame
Proof of an improvement in the muscle tone of the face based on the ratings and by measuring the photos

Secondary

MeasureTime frame
Proof of reinnervation of the facial muscles based on the ratings and by measuring the photos

Countries

Germany

Contacts

Public ContactGerd Fabian Volk

Fazialis-Nerv-Zentrum JenaKlinik für Hals-, Nasen- und Ohrenheilkunde am Universitätsklinikum Jena

Fabian.Volk@med.uni-jena.de036419329396

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026